08:51 AM EST, 11/14/2024 (MT Newswires) -- Health care stocks were steady pre-bell Thursday as the iShares Biotechnology ETF (IBB) was inactive and the Health Care Select Sector SPDR Fund (XLV) was up 0.1% recently.

ClearPoint Neuro ( CLPT ) shares were up over 9% after the company said the US Food and Drug Administration has granted de novo marketing authorization for its SmartFlow Neuro Cannula for the delivery of PTC Therapeutics' ( PTCT ) Kebilidi gene therapy to targeted regions within the brain.